McCormick, R., Blick, C., Ragoussis, J., Schoedel, J., Mole, D., Young, A., . . . Harris, A. (2013). miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.
Chicago Style (17th ed.) CitationMcCormick, R., C. Blick, J. Ragoussis, J. Schoedel, D. Mole, A. Young, P. Selby, R. Banks, and A. Harris. MiR-210 Is a Target of Hypoxia-inducible Factors 1 and 2 in Renal Cancer, Regulates ISCU and Correlates with Good Prognosis. 2013.
MLA (9th ed.) CitationMcCormick, R., et al. MiR-210 Is a Target of Hypoxia-inducible Factors 1 and 2 in Renal Cancer, Regulates ISCU and Correlates with Good Prognosis. 2013.
Warning: These citations may not always be 100% accurate.